Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BHCFX vs. QAAGZX: which is better?

Bottom line

BHCFX vs QAAGZX: the short answer

BHCFX (Baron Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.

But QAAGZX is far broader, holding 277 positions to 43 for BHCFX, so beyond the top names it adds exposure BHCFX doesn't have.

QAAGZX is cheaper at 0.86% vs 1.1% — a difference of $24 a year per $10,000 invested.

Over five years, QAAGZX returned +4.1% a year vs +2.5% for BHCFX.

Updated Nov 19, 2026

BHCFX vs QAAGZX side by side

BHCFXQAAGZX
TypeMutual fundETF
Fund familyBaron SelectT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.1%0.86%
Annual cost per $10k$110$86
10-yr cost on $10k (prospectus)$1,340$1,061
Max front load—None
12b-1 fee0.25%0%
1-yr return+10.0%+18.1%
5-yr return (annualized)+2.5%+4.1%
10-yr return (annualized)—+9.0%
Best quarter+24.6%+23.4%
Worst quarter−10.0%−15.8%
Net assets (fund)$114.1M$751.7M
Number of holdings43277
Portfolio turnover74%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBHCFXQAAGZXDifference
2025+10.0%+18.1%−8.1%
2024+1.3%+1.7%−0.4%
2023+6.2%+3.0%+3.2%
2022−17.1%−12.5%−4.6%
2021+15.5%+13.1%+2.4%
2020+47.4%+29.6%+17.8%
2019+35.2%+29.0%+6.3%

Source: Fund prospectus bar charts

Holdings overlap

13 of BHCFX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingBHCFXQAAGZX
Eli Lilly & Co13.66%14.06%
Johnson & Johnson5.56%6.64%
Thermo Fisher Scientific Inc3.91%2.53%
UnitedHealth Group Inc3.28%5.88%
Vertex Pharmaceuticals Inc2.61%2.26%
Merck & Co Inc2.48%4.00%
Guardant Health Inc2.17%1.22%
Kymera Therapeutics Inc2.01%0.89%
Gilead Sciences Inc1.99%2.79%
Natera Inc1.93%1.44%
Intuitive Surgical Inc1.74%1.89%
Protagonist Therapeutics Inc1.72%0.85%
Elevance Health Inc1.69%1.54%

Source: SEC Form N-PORT

BHCFX top 10

  1. Eli Lilly & Co — 13.66%
  2. Mettler-Toledo International Inc — 5.60%
  3. Johnson & Johnson — 5.56%
  4. Argenx SE — 4.23%
  5. Thermo Fisher Scientific Inc — 3.91%
  6. Roivant Sciences Ltd — 3.88%
  7. Teva Pharmaceutical Industries Ltd — 3.86%
  8. Welltower Inc — 3.38%
  9. UnitedHealth Group Inc — 3.28%
  10. RadNet Inc — 3.24%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between BHCFX and QAAGZX?
BHCFX (Baron Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds. But QAAGZX is far broader, holding 277 positions to 43 for BHCFX, so beyond the top names it adds exposure BHCFX doesn't have.
Which is cheaper, BHCFX or QAAGZX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both BHCFX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.